Executive summary of the consensus document on metabolic disorders and cardiovascular risk in patients with HIV infection

被引:4
|
作者
Polo Rodriguez, Rosa [1 ]
Galindo Puerto, Maria Jose [2 ]
Duenas, Carlos [3 ]
Gomez Candela, Carmen [4 ]
Estrada, Vicente [5 ]
Villar, Noemi G. P. [4 ]
Locutura, Jaime [6 ]
Marino, Ana [7 ]
Pascua, Javier
Palacios, Rosario [8 ]
Angel Von Wichmman, Miguel [9 ]
Alvarez, Julia [10 ]
Asensi, Victor [11 ]
Lopez Aldeguer, Jose [12 ]
Lozano, Fernando [13 ]
Negredo, Eugenia [14 ,15 ]
Ortega, Enrique [16 ]
Pedrol, Enric [17 ]
Gutierrez, Felix [18 ]
Sanz Sanz, Jesus [19 ]
Martinez Chamorro, Esteban [20 ]
机构
[1] Natl AIDS Plan, Madrid, Spain
[2] Hosp Clin Univ, Infect Dis Unit, Valencia, Spain
[3] Hosp Univ, Internal Med Infect Dis Unit, Burgos, Spain
[4] Hosp Univ La Paz, Madrid, Spain
[5] Hosp Clin Univ San Carlos, Infect Dis Unit, Madrid, Spain
[6] Univ Hosp, Infect Dis Unit, Burgos, Spain
[7] Hosp Arquitecto Marcide, Infect Dis Unit, Ferrol, Spain
[8] Hosp Virgen Victoria, Infect Dis Unit, Malaga, Spain
[9] Hosp Donostia, Infect Dis Unit, San Sebastian, Spain
[10] Hosp Univ Principe Asturias, Madrid, Spain
[11] Hosp Univ Cent Asturias, Infect Dis Unit, Oviedo, Spain
[12] Hosp La Fe, Infect Dis Unit, E-46009 Valencia, Spain
[13] Hosp Univ Valme, Infect Dis Unit, Seville, Spain
[14] Hosp Badalona Germans Trias & Pujol, Fundacio Lluita Sida, Lluita Fdn AIDS, Barcelona, Spain
[15] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[16] Hosp Univ Valencia, Infect Dis Unit, Valencia, Spain
[17] Hosp Figueres, Dept Internal Med, Girona, Spain
[18] Hosp Gen Univ, Infect Dis Unit, Elche, Spain
[19] Hosp Univ La Princesa, Infect Dis Unit, Madrid, Spain
[20] Hosp Univ Clin, Infect Dis Unit, Barcelona, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2015年 / 33卷 / 01期
关键词
HIV infection; Metabolic disorders; Cardiovascular risk;
D O I
10.1016/j.eimc.2014.05.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The importance of the metabolic disorders and their impact on patients with HIV infection requires an individualized study and continuous updating. HIV patients have the same cardiovascular risk factors as the general population. The HIV infection per se increases the cardiovascular risk, and metabolic disorders caused by some antiretroviral drugs are added risk factors. For this reason, the choice of drugs with a good metabolic profile is essential. The most common metabolic disorders of HIV infected-patients (insulin resistance, diabetes, hyperlipidemia or osteopenia), as well as other factors of cardiovascular risk, such as hypertension, should also be dealt with according to guidelines similar to the general population, as well as insisting on steps to healthier lifestyles. The aim of this document is to provide a query tool for all professionals who treat HIV-patients and who may present or display any metabolic disorders listed in this document. (C) 2014 Elsevier Espana, S.L.U. and Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. All rights reserved.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
  • [41] Management of Metabolic Complications and Cardiovascular Risk in HIV-Infected Patients
    Blanco, Francisco
    San Roman, Jesus
    Vispo, Eugenia
    Lopez, Mariola
    Salto, Antonio
    Abad, Vanesa
    Soriano, Vincent
    AIDS REVIEWS, 2010, 12 (04) : 231 - 241
  • [42] Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy
    Falasca, K.
    Ucciferri, C.
    Manzoli, L.
    Mancino, P.
    Pizzigallo, E.
    Conti, P.
    Vecchiet, J.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (03) : 519 - 527
  • [43] Cardiovascular disease in HIV-infected patients: does HIV infection in and of itself increase cardiovascular risk?
    Lo, Janet
    Grinspoon, Steven
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (03) : 207 - 213
  • [44] 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary
    Silka, Michael J.
    Shah, Maully J.
    Silva, Jennifer N. Avari
    Balaji, Seshadri
    Beach, Cheyenne M.
    Benjamin, Monica N.
    Berul, Charles, I
    Cannon, Bryan
    Cecchin, Frank
    Cohen, Mitchell, I
    Dalal, Aarti S.
    Dechert, Brynn E.
    Foster, Anne
    Gebauer, Roman
    Corcia, M. Cecilia Gonzalez
    Kannankeril, Prince J.
    Karpawich, Peter P.
    Kim, Jeffery J.
    Krishna, Mani Ram
    Kubus, Peter
    LaPage, Martin J.
    Mah, Douglas Y.
    Malloy-Walton, Lindsey
    Miyazaki, Aya
    Motonaga, Kara S.
    Niu, Mary C.
    Olen, Melissa
    Paul, Thomas
    Rosenthal, Eric
    Saarel, Elizabeth, V
    Silvetti, Massimo Stefano
    Stephenson, Elizabeth A.
    Tan, Reina B.
    Triedman, John
    Von Bergen, Nicholas H.
    Wackel, Philip L.
    ANNALS OF PEDIATRIC CARDIOLOGY, 2022, 15 (03) : 323 - 346
  • [45] 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: executive summary
    Silka, Michael J.
    Shah, Maully J.
    Silva, Jennifer N. Avari
    Balaji, Seshadri
    Beach, Cheyenne M.
    Benjamin, Monica N.
    Berul, Charles, I
    Cannon, Bryan
    Cecchin, Frank
    Cohen, Mitchell, I
    Dalal, Aarti S.
    Dechert, Brynn E.
    Foster, Anne
    Gebauer, Roman
    Corcia, M. Cecilia Gonzalez
    Kannankeril, Prince J.
    Karpawich, Peter P.
    Kim, Jeffery J.
    Krishna, Mani Ram
    Kubus, Peter
    LaPage, Martin J.
    Mah, Douglas Y.
    Malloy-Walton, Lindsey
    Miyazaki, Aya
    Motonaga, Kara S.
    Niu, Mary C.
    Olen, Melissa
    Paul, Thomas
    Rosenthal, Eric
    Saarel, Elizabeth, V
    Silvetti, Massimo Stefano
    Stephenson, Elizabeth A.
    Tan, Reina B.
    Triedman, John
    Von Bergen, Nicholas H.
    Wackel, Philip L.
    CARDIOLOGY IN THE YOUNG, 2021, 31 (11) : 1717 - 1737
  • [46] Dyslipidaemia and cardiovascular risk in HIV infection
    Kulasegaram, R
    Peters, BS
    Wierzbicki, AS
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (11) : 1717 - 1725
  • [47] ANMCO/AIOM/AICO Consensus Document on clinical and management pathways of cardio-oncology: executive summary
    Tarantini, Luigi
    Gulizia, Michele Massimo
    Di Lenarda, Andrea
    Maurea, Nicola
    Abrignani, Maurizio Giuseppe
    Bisceglia, Irma
    Bovelli, Daniella
    De Gennaro, Luisa
    Del Sindaco, Donatella
    Macera, Francesca
    Parrini, Iris
    Radini, Donatella
    Russo, Giulia
    Scardovi, Angela Beatrice
    Inno, Alessandro
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0D) : D370 - D379
  • [48] HIV Therapy, Metabolic Syndrome, and Cardiovascular Risk
    Pao, Vivian
    Lee, Grace A.
    Grunfeld, Carl
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (01) : 61 - 70
  • [49] Arterial hemodynamic parameters and cardiovascular risk in HIV patients with controlled infection
    Yannoutsos, Alexandra
    Ghosn, Jade
    Blacher, Jacques
    PRESSE MEDICALE, 2018, 47 (01): : 3 - 10
  • [50] Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV
    Nix, Linda M.
    Tien, Phyllis C.
    CURRENT HIV/AIDS REPORTS, 2014, 11 (03) : 271 - 278